Completed enrollment in Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG)
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
Seeking Alpha / 17 minutes ago 1 Views
Seeking Alpha / 17 minutes ago 1 Views
Completed enrollment in Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG)
Comments